Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CimCure Logo
CimCure Growth Score
63
CB Rank
125603
Heat Score
12
CimCure focuses on design and development of a novel class of active cancer immunotherapies.
Founded
obfuscation
PrivateSeed Amsterdam, Noord-Holland, The Netherlands1-10 cimcure.com/
Health Care
Medical
Overview

CimCure
Total Funding
obfuscation
Growth Score
63
Heat Score
12

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score63
-1 pts
in past quarter
Heat Score 12
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CimCure

CB Rank
125603
CimCure focuses on design and development of a novel class of active cancer immunotherapies.
Founded
obfuscation
PrivateSeed Amsterdam, Noord-Holland, The Netherlands1-10 cimcure.com/
Health Care
Medical

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name CimCure
Operating Status Active
Company Type For Profit
About the Company
CimCure focuses on the design and development of a novel class of active cancer immunotherapies. CimCure develops cancer vaccines using its unique Immune-Boost-tailored conjugate vaccination technology. It allows doctors to treat cancer more effectively by suppressing tumor growth.
Phone Number +31 646 336 338
Contact Email info@cimcure.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CVx1
A cancer vaccine that targets and destroys the blood vessels supplying tumors to inhibit cancer growth.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed
obfuscation
Seed Round - CimCure Logo
Seed Round - CimCure
2
obfuscation
Positron VenturesSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Tom Würdinger
Tom Würdinger
—
Seed Round - CimCure Logo
Seed Round - CimCure
—
Photo of Tom Würdinger
Tom Würdinger
—
Seed Round - CimCure Logo
Seed Round - CimCure
—
Photo of Tom Würdinger
Tom Würdinger
—
Seed Round - CimCure Logo
Seed Round - CimCure
—
Photo of Tom Würdinger
Tom Würdinger
—
Seed Round - CimCure Logo
Seed Round - CimCure
—
Photo of Tom Würdinger
Tom Würdinger
—
Seed Round - CimCure Logo
Seed Round - CimCure
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Jun 16, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 8, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

558
-44.86%
 in past month

Active Website Tech Count

2CimCure is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is CimCure's headquarters? CimCure is located in Amsterdam, Noord-Holland, The Netherlands.Who invested in CimCure? CimCure has 2 investors including Tom Würdinger and  Positron Ventures.When was the last funding round for CimCure? CimCure closed its last funding round on
obfuscation
from a Seed round.Who are CimCure's competitors? Alternatives and possible competitors to CimCure may include Moderna, Agenus, and  BioNTech.How much funding has CimCure raised to date? CimCure has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|